Ophthalmic Eye Dropper Market Share

North America Market Forecast

North America ophthalmic eye dropper market is expected to hold revenue share of more than 34.6% by 2037. The rising cases of eye disorders, the presence of advanced healthcare facilities, and continuous advancements in product formulation and delivery administration are augmenting the market growth in the region.

In the U.S., the high prevalence of eye disorders such as dry eyes, glaucoma, and cataracts is pushing the need for advanced ophthalmic eye care droppers. For instance, according to the Centers for Disease Control and Prevention, cataracts are a prime cause of vision loss in the U.S. and around 20.5 million individuals over 40 years of age are living with cataracts in both eyes and 6.1 million have replaced their lenses through operations. These statistics help to understand that with rise in the cases of eye disorders followed by operations is augmenting the demand for post-surgery ophthalmic eye drops, contributing to the overall market growth in the country.

In Canada, the presence of advanced healthcare facilities and research organizations such as the Association for Research in Vision and Ophthalmology and the Eye Care Foundation of Canada is contributing to the ophthalmic eye dropper market growth. These organizations play a vital role in the development of advanced ophthalmic eye care solutions including droppers.

Asia Pacific Market Statistics

The Asia Pacific market for ophthalmic eye droppers is projected to evolve at the fastest pace during the forecast period. The rising prevalence of eye disorders, increasing healthcare expenditure, and government awareness programs and reimbursement policies are contributing to the eye care solution sales including eye droppers.

In India, the government is investing more in advancing its healthcare infrastructure, such developments positively contribute to the medical and pharma sectors growth including ophthalmic eye droppers. For instance, according to the India Brand Equity Foundation, the Union budget 2024-2025 allocated USD 10.70 billion to transform its healthcare infrastructure.

China is witnessing a high prevalence of eye disorders including dry eye, which is directly fuelling the sales of ophthalmic eye droppers. As per Research Nester's analysis, around 21% to 30% of individuals above 40 years of age have dry eye disorder. As the prevalence rate rises, so does the ophthalmic eye dropper demand, generating profitable opportunities for key market players.